Cite
Development and evaluation of a CEACAM6-targeting theranostic nanomedicine for photoacoustic-based diagnosis and chemotherapy of metastatic cancer
MLA
Hyuncheol Kim, et al. “Development and Evaluation of a CEACAM6-Targeting Theranostic Nanomedicine for Photoacoustic-Based Diagnosis and Chemotherapy of Metastatic Cancer.” Theranostics, vol. 8, Jan. 2018, pp. 4247–61. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....59ee9b2517151bc50d68ff16cf45bd34&authtype=sso&custid=ns315887.
APA
Hyuncheol Kim, Hohyeon Lee, Park Suhyun, Eun-Joo Park, Hyejin Jang, Hyun-Jung Kim, & Yongho Jang. (2018). Development and evaluation of a CEACAM6-targeting theranostic nanomedicine for photoacoustic-based diagnosis and chemotherapy of metastatic cancer. Theranostics, 8, 4247–4261.
Chicago
Hyuncheol Kim, Hohyeon Lee, Park Suhyun, Eun-Joo Park, Hyejin Jang, Hyun-Jung Kim, and Yongho Jang. 2018. “Development and Evaluation of a CEACAM6-Targeting Theranostic Nanomedicine for Photoacoustic-Based Diagnosis and Chemotherapy of Metastatic Cancer.” Theranostics 8 (January): 4247–61. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....59ee9b2517151bc50d68ff16cf45bd34&authtype=sso&custid=ns315887.